semaglutide drug maker Ozempic, Wegovy-maker hires lobbying firm to push for Medicare coverage Ozempic-maker Novo Nordisk to cut

All participants were 18 years or older, planned to initiate HCV antiviral treatment, and provided written informed consent to participate in a single-center, open-label study (ClinicalTrials.gov Identifier: NCT02734173), which was approved by The Ottawa Health Science Network Research Ethics Board (REB 2015-0305, Ottawa, Ontario, Canada)

August 2021: Ozempic Could Be Linked to Increased Risk of Diabetic Retinopathy Study results examining diabetic retinopathy (DR) in patients taking semaglutide found a higher risk for DR complications in patients with proliferative and non-proliferative DR at baseline. However, researchers acknowledge that worsening DR could be due to rapid drops in blood glucose levels from diabetic medications

However, if you have constipation that lasts three weeks or longer, contact your doctor to be safe

The severity of these injuries varies considerably